Literature DB >> 16293766

Is dehydroepiandrosterone a hormone?

F Labrie1, V Luu-The, A Bélanger, S-X Lin, J Simard, G Pelletier, C Labrie.   

Abstract

Dehydroepiandrosterone (DHEA) is not a hormone but it is a very important prohormone secreted in large amounts by the adrenals in humans and other primates, but not in lower species. It is secreted in larger quantities than cortisol and is present in the blood at concentrations only second to cholesterol. All the enzymes required to transform DHEA into androgens and/or estrogens are expressed in a cell-specific manner in a large series of peripheral target tissues, thus permitting all androgen-sensitive and estrogen-sensitive tissues to make locally and control the intracellular levels of sex steroids according to local needs. This new field of endocrinology has been called intracrinology. In women, after menopause, all estrogens and almost all androgens are made locally in peripheral tissues from DHEA which indirectly exerts effects, among others, on bone formation, adiposity, muscle, insulin and glucose metabolism, skin, libido and well-being. In men, where the secretion of androgens by the testicles continues for life, the contribution of DHEA to androgens has been best evaluated in the prostate where about 50% of androgens are made locally from DHEA. Such knowledge has led to the development of combined androgen blockade (CAB), a treatment which adds a pure anti-androgen to medical (GnRH agonist) or surgical castration in order to block the access of the androgens made locally to the androgen receptor. In fact, CAB has been the first treatment demonstrated to prolong life in advanced prostate cancer while recent data indicate that it can permit long-term control and probably cure in at least 90% of cases of localized prostate cancer. The new field of intracrinology or local formation of sex steroids from DHEA in target tissues has permitted major advances in the treatment of the two most frequent cancers, namely breast and prostate cancer, while its potential use as a physiological HRT could well provide a physiological balance of androgens and estrogens, thus offering exciting possibilities for women's health at menopause.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16293766     DOI: 10.1677/joe.1.06264

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  80 in total

1.  The utility and dynamics of salivary sex hormone measurements in the National Social Life, Health, and Aging Project, Wave 2.

Authors:  Michael J Kozloski; L Philip Schumm; Martha K McClintock
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2014-11       Impact factor: 4.077

2.  Phase I and Phase II clinical trials of androst-5-ene-3β,7β,17β-triol.

Authors:  Dwight R Stickney; Clarence N Ahlem; Elizabeth Morgan; Christopher L Reading; Nanette Onizuka; James M Frincke
Journal:  Am J Transl Res       Date:  2011-04-12       Impact factor: 4.060

Review 3.  The Adaptive Calibration Model of stress responsivity.

Authors:  Marco Del Giudice; Bruce J Ellis; Elizabeth A Shirtcliff
Journal:  Neurosci Biobehav Rev       Date:  2010-12-08       Impact factor: 8.989

4.  Human adrenal cells that express both 3β-hydroxysteroid dehydrogenase type 2 (HSD3B2) and cytochrome b5 (CYB5A) contribute to adrenal androstenedione production.

Authors:  Yasuhiro Nakamura; Yewei Xing; Xiao-Gang Hui; Yumi Kurotaki; Katsuhiko Ono; Tony Cohen; Hironobu Sasano; William E Rainey
Journal:  J Steroid Biochem Mol Biol       Date:  2010-12-23       Impact factor: 4.292

Review 5.  Can endocrine disruptors influence neuroplasticity in the aging brain?

Authors:  Bernard Weiss
Journal:  Neurotoxicology       Date:  2007-02-04       Impact factor: 4.294

6.  Type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) contributes to testosterone production in the adrenal reticularis.

Authors:  Yasuhiro Nakamura; Peter J Hornsby; Peter Casson; Ryo Morimoto; Fumitoshi Satoh; Yewei Xing; Michael R Kennedy; Hironobu Sasano; William E Rainey
Journal:  J Clin Endocrinol Metab       Date:  2009-03-31       Impact factor: 5.958

7.  A new antidiabetic compound attenuates inflammation and insulin resistance in Zucker diabetic fatty rats.

Authors:  Min Lu; David Patsouris; Pingping Li; Jaime Flores-Riveros; James M Frincke; Steve Watkins; Simon Schenk; Jerrold M Olefsky
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-02-16       Impact factor: 4.310

8.  Mice lacking β-carotene-15,15'-dioxygenase exhibit reduced serum testosterone, prostatic androgen receptor signaling, and prostatic cellular proliferation.

Authors:  Joshua W Smith; Nikki A Ford; Jennifer M Thomas-Ahner; Nancy E Moran; Eric C Bolton; Matthew A Wallig; Steven K Clinton; John W Erdman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-09-14       Impact factor: 3.619

Review 9.  Adrenal changes associated with adrenarche.

Authors:  Yasuhiro Nakamura; Hui Xiao Gang; Takashi Suzuki; Hironobu Sasano; William E Rainey
Journal:  Rev Endocr Metab Disord       Date:  2009-03       Impact factor: 6.514

10.  Why egalitarianism might be good for your health: physiological thriving during stressful intergroup encounters.

Authors:  Wendy Berry Mendes; Heather M Gray; Rodolfo Mendoza-Denton; Brenda Major; Elissa S Epel
Journal:  Psychol Sci       Date:  2007-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.